학술논문

Effects of rapamycin in combination with fludarabine on primary chronic lymphocytic leukemia cells.
Document Type
Article
Source
Leukemia & Lymphoma. May2019, Vol. 60 Issue 5, p1299-1303. 5p.
Subject
*CHRONIC lymphocytic leukemia
*BONE marrow cells
*BCL-2 proteins
*B cell receptors
*CELLS
Language
ISSN
1042-8194
Abstract
The article notes the effects of rapamycin in combination with fludarabine on primary chronic lymphocytic leukemia (CLL) cells. Topic includes analysing the synergistic effect in cells by combining them with fludarabine treatment in peripheral blood mononuclear cells (PBMC) from Chronic lymphocytic leukemia patients, evaluating B-cell lymphoma (BCL-2) in CLL patients, and using purine analogs in combination with other pharmacological agents for CLL therapy.